Cholecystectomy was deferred in the majority of patients with acute cholecystitis in our hospital due to limitation of operative rooms and the COVID-19 pandemic. Recurrent cholecystitis Endoscopic transpapillary gallbladder stenting Delayed cholecystectomy
Conditions
Interventions
Endoscopic transpapillary gallbladder stenting (ETGS),No endoscopic transpapillary gallbladder stenting (ETGS)
Sponsors
Excellence Center for Gastrointestinal Endoscopy, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with acute cholecystitis who had a high probability of CBD stone and had cholecystectomy deferral (at 3 months or later after the onset of symptoms)
Exclusion criteria
Exclusion criteria: Gallbladder perforation, septic cholangitis with irreversible severe co-morbid illness, severe coagulopathy, previous ERCP with CBD stone removal, and patients who refused to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of recurrent cholecystitis after ETGS in acute cholecystitis patients with deferred cholecystectomy who received and did not receive ETGS 3 months Percentage | — |
Secondary
| Measure | Time frame |
|---|---|
| The rate of recurrent cholecystitis after ETGS in acute cholecystitis patients with deferred cholecystectomy who received and did not receive ETGS 6 months Percentage,ETGS procedure-related adverse events 2 weeks Percentage,Technical success rate At procedure Percentage,Clinical success rate 72 hours Percentage | — |
Countries
Thailand
Contacts
Public ContactWiriyaporn Ridtitid
Faculty of Medicine, Chulalongkorn University
Outcome results
None listed